Home page8086 • TYO
add
Nipro Corp
Chiusura precedente
1.417,00 ¥
Intervallo giornaliero
1.414,00 ¥ - 1.426,50 ¥
Intervallo annuale
1.070,50 ¥ - 1.480,00 ¥
Cap di mercato
243,39 Mrd JPY
Volume medio
696.553,00
Rapporto P/E
27,68
Dividendo/Prezzo
1,76%
Borsa valori principale
TYO
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (JPY) | giu 2024info | Variazione Y/Y |
|---|---|---|
Entrate | 152,39 Mrd | 8,39% |
Spese di gestione | 40,10 Mrd | 12,23% |
Utile netto | 2,63 Mrd | -35,94% |
Margine di profitto netto | 1,72 | -41,10% |
Utili per azione | — | — |
EBITDA | 20,53 Mrd | 5,13% |
Aliquota fiscale effettiva | 50,72% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (JPY) | giu 2024info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 83,60 Mrd | -5,06% |
Totale attivo | 1,14 Bln | 9,23% |
Totale passivo | 852,26 Mrd | 7,68% |
Patrimonio netto totale | 284,44 Mrd | — |
Azioni in circolazione | 163,10 Mln | — |
Prezzo/valore contabile | 0,94 | — |
Redditività dell'attivo | 1,29% | — |
Rendimento sul capitale | 1,58% | — |
Flusso di cassa
Flusso di cassa netto
| (JPY) | giu 2024info | Variazione Y/Y |
|---|---|---|
Utile netto | 2,63 Mrd | -35,94% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.
April 1, 2019, the ethical pharmaceutical sales division of subsidiary Nipro ES Pharma Corporation is integrated into our domestic business division, Pharmaceutical Sales Division.
April 1, 2023, the Company's head office will be relocated to a new building constructed on the Company's own land in Kento Innovation Park in Settsu City. The registered head office and the location of the manufacturing and sales office based on the Law Concerning Assurance of Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices and Other Products are scheduled to be relocated in October of the same year. Wikipedia
Fondazione
8 lug 1954
Sito web
Dipendenti
38.117
